LOADING
Comparing Johnson & Johnson (JNJ) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | CRM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $658.0B | $161.7B |
| P/E Ratio | 31.4 | 24.2 |
| Forward P/E | 23.2 | 15.4 |
| PEG Ratio | 4.73 | 0.87 |
| EPS | $8.71 | $8.64 |
| Revenue Growth (YoY) | 6.6% | 13.3% |
| Profit Margin | 21.5% | 18.7% |
| Return on Equity | 25.7% | 16.9% |
| Dividend Yield | 1.94% | 0.82% |
| Beta | 0.23 | 1.15 |
| 52-Week High | $275.11 | $267.75 |
| 52-Week Low | $169.49 | $146.32 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.